TABLE 1.
Condition and treatmenta |
Cellularity | Hemocyte subsetb
|
Nodule |
C. albicansc | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Pr | Gr | Pl | Co | Sp | Ad | Oe | Size | Melanization | |||
In vitro | |||||||||||
CTR | Low | + | + | − | − | + | + | − | − | − | − |
SC5314 | High | + | ++ | ++ | ++ | ++ | + | + | Medium | ++ | +++ |
ACh | High | + | ++ | +++ | + | − | − | − | Medium | − | − |
PHCl | Low | + | + | − | − | + | + | − | − | − | − |
SC5314/ACh | High | + | +++ | +++ | ++ | + | + | − | Large | − | + |
SC5314/PHCl | High | + | + | +++ | + | + | ++ | + | Small | − | + |
In vivo | |||||||||||
CTR | Low | + | + | − | − | + | + | − | − | − | − |
SC5314 | High | + | +++ | ++ | ++ | ++ | + | + | Large | +++ | +++ |
ACh | Intermediate | + | ++ | +++ | + | − | − | − | Medium | − | − |
PHCl | Low | + | + | + | − | + | + | − | − | − | − |
SC5314/ACh | Intermediate | + | +++ | +++ | ++ | + | + | + | Large | − | + |
SC5314/PHCl | Intermediate | + | ++ | +++ | ++ | + | + | + | Small | − | + |
Galleria mellonella larvae were inoculated with PBS (control [CTR]), C. albicans SC5314, acetylcholine (ACh), pilocarpine hydrochloride (PHCl), C. albicans plus ACh (SC3514/ACh), and C. albicans plus PHCl (SC5314/PHCl).
Pr, prohemocytes; Gr, granulocytes; Pl, plasmatocytes; Co, coagulocytes; Sp, spherulocytes; Ad, adipocytes; Oe, oenocytes. Immune cell subtype quantification was scored as follows: −, absent/rare; +, 1 to 10%; ++, 11 to 30%; +++, 31 to 50%.
C. albicans presence was quantified as follows: −, absent; +, few cells; ++, multiple yeast agglomerate usually embedded in nodules; +++, abundant yeasts and/or hyphae with widespread diffusion in nodules.